 | • レポートコード：D005-13167 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、組換えタンパク質薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。組換えタンパク質薬の種類別市場規模（リコンビナントDNA、リコンビナントRNA）、用途別市場規模（製薬産業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novo Nordisk、Kyowa Hakko Kirin、Eli Lilly、Amgen、Roche、Sanofi、Abcam、Ortho Biotech、Merck Serono、Pharmingen、NCPC、GenSci、Heng Rui、Ankebio、SL PHARM、Dongbao Pharm ・地域別グローバル市場分析 2015年-2020年 ・組換えタンパク質薬の北米市場（アメリカ、カナダ、メキシコ） ・組換えタンパク質薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・組換えタンパク質薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・組換えタンパク質薬の南米市場（ブラジル、アルゼンチン） ・組換えタンパク質薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：リコンビナントDNA、リコンビナントRNA ・用途別分析：製薬産業、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Recombinant Protein Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Recombinant Protein Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Recombinant Protein Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Recombinant Protein Drugs market has been segmented into
Recombinant DNA
Recombinant RNA
By Application, Recombinant Protein Drugs has been segmented into:
Pharmaceutical Industry
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Recombinant Protein Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Recombinant Protein Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Recombinant Protein Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Recombinant Protein Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Recombinant Protein Drugs Market Share Analysis
Recombinant Protein Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Recombinant Protein Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Recombinant Protein Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Recombinant Protein Drugs are:
Novo Nordisk
Kyowa Hakko Kirin
Eli Lilly
Amgen
Roche
Sanofi
Abcam
Ortho Biotech
Merck Serono
Pharmingen
NCPC
GenSci
Heng Rui
Ankebio
SL PHARM
Dongbao Pharm
Among other players domestic and global, Recombinant Protein Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Protein Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Protein Drugs, with price, sales, revenue and global market share of Recombinant Protein Drugs in 2018 and 2019.
Chapter 3, the Recombinant Protein Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Protein Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Recombinant Protein Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Recombinant Protein Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Recombinant Protein Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Protein Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Recombinant DNA
1.2.3 Recombinant RNA
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Protein Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical Industry
1.3.3 Other
1.4 Overview of Global Recombinant Protein Drugs Market
1.4.1 Global Recombinant Protein Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novo Nordisk SWOT Analysis
2.1.4 Novo Nordisk Product and Services
2.1.5 Novo Nordisk Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kyowa Hakko Kirin
2.2.1 Kyowa Hakko Kirin Details
2.2.2 Kyowa Hakko Kirin Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kyowa Hakko Kirin SWOT Analysis
2.2.4 Kyowa Hakko Kirin Product and Services
2.2.5 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen SWOT Analysis
2.4.4 Amgen Product and Services
2.4.5 Amgen Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Abcam
2.7.1 Abcam Details
2.7.2 Abcam Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Abcam SWOT Analysis
2.7.4 Abcam Product and Services
2.7.5 Abcam Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Ortho Biotech
2.8.1 Ortho Biotech Details
2.8.2 Ortho Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Ortho Biotech SWOT Analysis
2.8.4 Ortho Biotech Product and Services
2.8.5 Ortho Biotech Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck Serono
2.9.1 Merck Serono Details
2.9.2 Merck Serono Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck Serono SWOT Analysis
2.9.4 Merck Serono Product and Services
2.9.5 Merck Serono Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pharmingen
2.10.1 Pharmingen Details
2.10.2 Pharmingen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pharmingen SWOT Analysis
2.10.4 Pharmingen Product and Services
2.10.5 Pharmingen Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 NCPC
2.11.1 NCPC Details
2.11.2 NCPC Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 NCPC SWOT Analysis
2.11.4 NCPC Product and Services
2.11.5 NCPC Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 GenSci
2.12.1 GenSci Details
2.12.2 GenSci Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 GenSci SWOT Analysis
2.12.4 GenSci Product and Services
2.12.5 GenSci Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Heng Rui
2.13.1 Heng Rui Details
2.13.2 Heng Rui Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Heng Rui SWOT Analysis
2.13.4 Heng Rui Product and Services
2.13.5 Heng Rui Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Ankebio
2.14.1 Ankebio Details
2.14.2 Ankebio Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Ankebio SWOT Analysis
2.14.4 Ankebio Product and Services
2.14.5 Ankebio Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 SL PHARM
2.15.1 SL PHARM Details
2.15.2 SL PHARM Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 SL PHARM SWOT Analysis
2.15.4 SL PHARM Product and Services
2.15.5 SL PHARM Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Dongbao Pharm
2.16.1 Dongbao Pharm Details
2.16.2 Dongbao Pharm Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Dongbao Pharm SWOT Analysis
2.16.4 Dongbao Pharm Product and Services
2.16.5 Dongbao Pharm Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Recombinant Protein Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Recombinant Protein Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Protein Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Recombinant Protein Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Recombinant Protein Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Protein Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Recombinant Protein Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
4.5 South America Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Recombinant Protein Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Protein Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Recombinant Protein Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Recombinant Protein Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Protein Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Recombinant Protein Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
6.3 UK Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
6.4 France Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Recombinant Protein Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Recombinant Protein Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Recombinant Protein Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
7.5 India Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Recombinant Protein Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Protein Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Recombinant Protein Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Recombinant Protein Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Recombinant Protein Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Recombinant Protein Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Recombinant Protein Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Recombinant Protein Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Recombinant Protein Drugs Price by Type (2015-2020)
11 Global Recombinant Protein Drugs Market Segment by Application
11.1 Global Recombinant Protein Drugs Sales Market Share by Application (2015-2020)
11.2 Global Recombinant Protein Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Recombinant Protein Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Recombinant Protein Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Recombinant Protein Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Recombinant Protein Drugs Market Forecast (2021-2025)
12.2.2 Europe Recombinant Protein Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Recombinant Protein Drugs Market Forecast (2021-2025)
12.2.4 South America Recombinant Protein Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Recombinant Protein Drugs Market Forecast (2021-2025)
12.3 Recombinant Protein Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Recombinant Protein Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Recombinant Protein Drugs Market Share Forecast by Type (2021-2025)
12.4 Recombinant Protein Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Recombinant Protein Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Recombinant Protein Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Recombinant Protein Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant Protein Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant Protein Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 8. Novo Nordisk Recombinant Protein Drugs Major Business
Table 9. Novo Nordisk Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Novo Nordisk SWOT Analysis
Table 11. Novo Nordisk Recombinant Protein Drugs Product and Services
Table 12. Novo Nordisk Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 14. Kyowa Hakko Kirin Recombinant Protein Drugs Major Business
Table 15. Kyowa Hakko Kirin Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Kyowa Hakko Kirin SWOT Analysis
Table 17. Kyowa Hakko Kirin Recombinant Protein Drugs Product and Services
Table 18. Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly Recombinant Protein Drugs Major Business
Table 21. Eli Lilly Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Eli Lilly SWOT Analysis
Table 23. Eli Lilly Recombinant Protein Drugs Product and Services
Table 24. Eli Lilly Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Amgen Basic Information, Manufacturing Base and Competitors
Table 26. Amgen Recombinant Protein Drugs Major Business
Table 27. Amgen Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Amgen SWOT Analysis
Table 29. Amgen Recombinant Protein Drugs Product and Services
Table 30. Amgen Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Roche Basic Information, Manufacturing Base and Competitors
Table 32. Roche Recombinant Protein Drugs Major Business
Table 33. Roche Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Roche SWOT Analysis
Table 35. Roche Recombinant Protein Drugs Product and Services
Table 36. Roche Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Sanofi Basic Information, Manufacturing Base and Competitors
Table 38. Sanofi Recombinant Protein Drugs Major Business
Table 39. Sanofi Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Sanofi SWOT Analysis
Table 41. Sanofi Recombinant Protein Drugs Product and Services
Table 42. Sanofi Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Abcam Basic Information, Manufacturing Base and Competitors
Table 44. Abcam Recombinant Protein Drugs Major Business
Table 45. Abcam Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Abcam SWOT Analysis
Table 47. Abcam Recombinant Protein Drugs Product and Services
Table 48. Abcam Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Ortho Biotech Basic Information, Manufacturing Base and Competitors
Table 50. Ortho Biotech Recombinant Protein Drugs Major Business
Table 51. Ortho Biotech Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Ortho Biotech SWOT Analysis
Table 53. Ortho Biotech Recombinant Protein Drugs Product and Services
Table 54. Ortho Biotech Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 56. Merck Serono Recombinant Protein Drugs Major Business
Table 57. Merck Serono Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Merck Serono SWOT Analysis
Table 59. Merck Serono Recombinant Protein Drugs Product and Services
Table 60. Merck Serono Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Pharmingen Basic Information, Manufacturing Base and Competitors
Table 62. Pharmingen Recombinant Protein Drugs Major Business
Table 63. Pharmingen Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Pharmingen SWOT Analysis
Table 65. Pharmingen Recombinant Protein Drugs Product and Services
Table 66. Pharmingen Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. NCPC Basic Information, Manufacturing Base and Competitors
Table 68. NCPC Recombinant Protein Drugs Major Business
Table 69. NCPC Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 70. NCPC SWOT Analysis
Table 71. NCPC Recombinant Protein Drugs Product and Services
Table 72. NCPC Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. GenSci Basic Information, Manufacturing Base and Competitors
Table 74. GenSci Recombinant Protein Drugs Major Business
Table 75. GenSci Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 76. GenSci SWOT Analysis
Table 77. GenSci Recombinant Protein Drugs Product and Services
Table 78. GenSci Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Heng Rui Basic Information, Manufacturing Base and Competitors
Table 80. Heng Rui Recombinant Protein Drugs Major Business
Table 81. Heng Rui Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Heng Rui SWOT Analysis
Table 83. Heng Rui Recombinant Protein Drugs Product and Services
Table 84. Heng Rui Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Ankebio Basic Information, Manufacturing Base and Competitors
Table 86. Ankebio Recombinant Protein Drugs Major Business
Table 87. Ankebio Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Ankebio SWOT Analysis
Table 89. Ankebio Recombinant Protein Drugs Product and Services
Table 90. Ankebio Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. SL PHARM Basic Information, Manufacturing Base and Competitors
Table 92. SL PHARM Recombinant Protein Drugs Major Business
Table 93. SL PHARM Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 94. SL PHARM SWOT Analysis
Table 95. SL PHARM Recombinant Protein Drugs Product and Services
Table 96. SL PHARM Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Dongbao Pharm Basic Information, Manufacturing Base and Competitors
Table 98. Dongbao Pharm Recombinant Protein Drugs Major Business
Table 99. Dongbao Pharm Recombinant Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 100. Dongbao Pharm SWOT Analysis
Table 101. Dongbao Pharm Recombinant Protein Drugs Product and Services
Table 102. Dongbao Pharm Recombinant Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Global Recombinant Protein Drugs Sales by Manufacturer (2018-2019) (K Doses)
Table 104. Global Recombinant Protein Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 105. Global Recombinant Protein Drugs Sales by Regions (2015-2020) (K Doses)
Table 106. Global Recombinant Protein Drugs Sales Market Share by Regions (2015-2020)
Table 107. Global Recombinant Protein Drugs Revenue by Regions (2015-2020) (USD Million)
Table 108. North America Recombinant Protein Drugs Sales by Countries (2015-2020) (K Doses)
Table 109. North America Recombinant Protein Drugs Sales Market Share by Countries (2015-2020)
Table 110. North America Recombinant Protein Drugs Revenue by Countries (2015-2020) (USD Million)
Table 111. North America Recombinant Protein Drugs Revenue Market Share by Countries (2015-2020)
Table 112. Europe Recombinant Protein Drugs Sales by Countries (2015-2020) (K Doses)
Table 113. Europe Recombinant Protein Drugs Sales Market Share by Countries (2015-2020)
Table 114. Europe Recombinant Protein Drugs Revenue by Countries (2015-2020) (USD Million)
Table 115. Asia-Pacific Recombinant Protein Drugs Sales by Regions (2015-2020) (K Doses)
Table 116. Asia-Pacific Recombinant Protein Drugs Sales Market Share by Regions (2015-2020)
Table 117. Asia-Pacific Recombinant Protein Drugs Revenue by Regions (2015-2020) (USD Million)
Table 118. South America Recombinant Protein Drugs Sales by Countries (2015-2020) (K Doses)
Table 119. South America Recombinant Protein Drugs Sales Market Share by Countries (2015-2020)
Table 120. South America Recombinant Protein Drugs Revenue by Countries (2015-2020) (USD Million)
Table 121. South America Recombinant Protein Drugs Revenue Market Share by Countries (2015-2020)
Table 122. Middle East & Africa Recombinant Protein Drugs Sales by Countries (2015-2020) (K Doses)
Table 123. Middle East & Africa Recombinant Protein Drugs Sales Market Share by Countries (2015-2020)
Table 124. Middle East & Africa Recombinant Protein Drugs Revenue by Countries (2015-2020) (USD Million)
Table 125. Middle East & Africa Recombinant Protein Drugs Revenue Market Share by Countries (2015-2020)
Table 126. Global Recombinant Protein Drugs Sales by Type (2015-2020) (K Doses)
Table 127. Global Recombinant Protein Drugs Sales Share by Type (2015-2020)
Table 128. Global Recombinant Protein Drugs Revenue by Type (2015-2020) (USD Million)
Table 129. Global Recombinant Protein Drugs Revenue Share by Type (2015-2020)
Table 130. Global Recombinant Protein Drugs Sales by Application (2015-2020) (K Doses)
Table 131. Global Recombinant Protein Drugs Sales Share by Application (2015-2020)
Table 132. Global Recombinant Protein Drugs Sales Forecast by Regions (2021-2025) (K Doses)
Table 133. Global Recombinant Protein Drugs Market Share Forecast by Regions (2021-2025)
Table 134. Global Recombinant Protein Drugs Sales Forecast by Type (2021-2025) (K Doses)
Table 135. Global Recombinant Protein Drugs Market Share Forecast by Type (2021-2025)
Table 136. Global Recombinant Protein Drugs Sales Forecast by Application (2021-2025)
Table 137. Global Recombinant Protein Drugs Market Share Forecast by Application (2021-2025)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Recombinant Protein Drugs Picture
Figure 2. Global Sales Market Share of Recombinant Protein Drugs by Type in 2019
Figure 3. Recombinant DNA Picture
Figure 4. Recombinant RNA Picture
Figure 5. Recombinant Protein Drugs Sales Market Share by Application in 2018
Figure 6. Pharmaceutical Industry Picture
Figure 7. Other Picture
Figure 8. Global Recombinant Protein Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Recombinant Protein Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Recombinant Protein Drugs Sales Market Share by Manufacturer in 2019
Figure 29. Global Recombinant Protein Drugs Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Recombinant Protein Drugs Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Recombinant Protein Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 34. Global Recombinant Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Recombinant Protein Drugs Revenue Market Share by Regions (2015-2020)
Figure 36. Global Recombinant Protein Drugs Revenue Market Share by Regions in 2018
Figure 37. North America Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
Figure 38. Europe Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
Figure 40. South America Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Recombinant Protein Drugs Sales and Growth Rate (2015-2020)
Figure 42. North America Recombinant Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Recombinant Protein Drugs Sales Market Share by Countries (2015-2020)
Figure 44. North America Recombinant Protein Drugs Sales Market Share by Countries in 2018
Figure 45. North America Recombinant Protein Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Recombinant Protein Drugs Revenue Market Share by Countries in 2018
Figure 47. United States Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 48. Canada Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 49. Mexico Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Europe Recombinant Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Recombinant Protein Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Recombinant Protein Drugs Revenue Market Share by Countries in 2019
Figure 53. Germany Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. UK Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. France Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. Russia Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. Italy Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Asia-Pacific Recombinant Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Recombinant Protein Drugs Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Recombinant Protein Drugs Revenue Market Share by Regions 2019
Figure 61. China Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Japan Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Korea Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. India Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Southeast Asia Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. South America Recombinant Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Recombinant Protein Drugs Sales Market Share by Countries in 2019
Figure 68. South America Recombinant Protein Drugs Revenue Market Share by Countries in 2019
Figure 69. Brazil Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 70. Argentina Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Middle East and Africa Recombinant Protein Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Recombinant Protein Drugs Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Recombinant Protein Drugs Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Recombinant Protein Drugs Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 76. Egypt Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Turkey Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. South Africa Recombinant Protein Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Global Recombinant Protein Drugs Sales and Growth Rate (2021-2025) (K Doses)
Figure 80. Global Recombinant Protein Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Recombinant Protein Drugs Market Forecast (2021-2025) (K Doses)
Figure 82. Europe Sales Recombinant Protein Drugs Market Forecast (2021-2025) (K Doses)
Figure 83. Asia-Pacific Sales Recombinant Protein Drugs Market Forecast (2021-2025) (K Doses)
Figure 84. South America Sales Recombinant Protein Drugs Market Forecast (2021-2025) (K Doses)
Figure 85. Middle East & Africa Sales Recombinant Protein Drugs Market Forecast (2021-2025) (K Doses)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
組換えグリコシル化タンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Glycosylated Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant …- 組み換え非グリコシル化タンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Non-glycosylated Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombin…
- 治療用組換えタンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Therapeutic Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant T…
- 組換えワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD 935.1 million by 2025, from USD 822.7 million in 2019. The Recombinant Vacci…
- 組換えヒトエンドスタチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant Huma…